ArticlePharmaceutical research2016

Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.

George Mattheolabakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.